| Medi Home Health Agency Inc | |
| 201 Penn Center Blvd Ste 300, Pittsburgh, Pennsylvania 15235 | |
| (412) 242-8540 | |
| Name | Medi Home Health Agency Inc |
|---|---|
| Location | 201 Penn Center Blvd Ste 300, Pittsburgh, Pennsylvania |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 397607 |
| Ownership Type | Voluntary Non-profit - Other |
| Service Area Zip Codes | 15001, 15003, 15005, 15009, 15010, 15012, 15014, 15017, 15022, 15024, 15025, 15030, 15033, 15034, 15035, 15037, 15043, 15044, 15046, 15059, 15062, 15063, 15065, 15066, 15068, 15076, 15084, 15085, 15088, 15090, 15102, 15104, 15106, 15108, 15110, 15112, 15120, 15122, 15129, 15131, 15132, 15133, 15136, 15137, 15139, 15140, 15143, 15144, 15145, 15146, 15147, 15148, 15201, 15202, 15204, 15205, 15206, 15207, 15208, 15209, 15211, 15212, 15214, 15215, 15216, 15217, 15219, 15220, 15221, 15223, 15224, 15226, 15227, 15228, 15229, 15232, 15234, 15235, 15236, 15237, 15238, 15239, 15241, 15243, 15301, 15314, 15317, 15322, 15325, 15331, 15332, 15342, 15358, 15367, 15370, 15401, 15412, 15413, 15425, 15438, 15447, 15450, 15456, 15458, 15461, 15464, 15469, 15470, 15473, 15490, 15501, 15521, 15531, 15552, 15601, 15610, 15611, 15613, 15615, 15622, 15623, 15626, 15627, 15632, 15636, 15637, 15639, 15642, 15644, 15650, 15656, 15658, 15661, 15665, 15666, 15668, 15670, 15672, 15673, 15675, 15677, 15681, 15683, 15687, 15688, 15690, 15692, 15697, 15698, 15701, 15710, 15714, 15716, 15717, 15732, 15734, 15742, 15747, 15748, 15774, 15901, 15906, 15920, 15923, 15931, 15944, 15946, 16001, 16002, 16023, 16033, 16037, 16038, 16046, 16048, 16050, 16053, 16055, 16056, 16057, 16061, 16063, 16066, 16101, 16115, 16117, 16123, 16127, 16136, 16137, 16141, 16156, 16160, 16201, 16222, 16226, 16229 |
| NPI Number | 1144645813 |
| Organization Name | NIGHTINGALE HOME HEALTHCARE OF NORTHERN CALIFORNIA INC. |
| Doing Business As | ASPIRE HOME HEALTHCARE OF NORTHERN CALIFORNIA |
| Address | 545 Forbes Ave, Yuba City, CA 95991 |
| Phone Number | 866-334-7777 |
News Archive
The most productive way scientists have devised to nurture colonies of human embryonic stem cells is to do so atop a bed of mouse cells. That may be fine for lab research, but it poses an unacceptable contamination risk for stem cells intended for transplant into human patients. In a new study, Brown University bioengineers have developed a synthetic bed that works about as well as the mouse cells, called fibroblasts, without any possibility of contamination.
A new paper describes the development and validation of a rapid test to measure the neutralizing activity of serum against COVID-19 using a drop of blood.
It is unlikely that different types of depression can be combined to one single disease called Major Depression. When testing the efficacy of antidepressants or psychotherapy, clinicians should make an attempt to specify the subtypes of depression and to combine antidepressants and psychotherapy in a sequential approach.
Using a technique that enables them to study both early and advanced stages of arterial plaque buildup in the same mice, researchers at Cedars-Sinai Medical Center found that an antioxidant compound found in green tea leaves does not clear established plaque but does inhibit the development of new deposits.
Micromet, Inc. today announced that it has initiated a phase 2 trial of its lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE® antibodies, designed to harness the body's T cells to kill cancer cells.
› Verified 4 days ago
| NPI Number | 1346578747 |
| Organization Name | NIGHTINGALE HOME HEALTHCARE OF WESTERN PENNSYLVANIA, INC. |
| Address | 201 Penn Center Blvd, Suite 105, Pittsburgh, PA 15235 |
| Phone Number | 866-334-7777 |
News Archive
The most productive way scientists have devised to nurture colonies of human embryonic stem cells is to do so atop a bed of mouse cells. That may be fine for lab research, but it poses an unacceptable contamination risk for stem cells intended for transplant into human patients. In a new study, Brown University bioengineers have developed a synthetic bed that works about as well as the mouse cells, called fibroblasts, without any possibility of contamination.
A new paper describes the development and validation of a rapid test to measure the neutralizing activity of serum against COVID-19 using a drop of blood.
It is unlikely that different types of depression can be combined to one single disease called Major Depression. When testing the efficacy of antidepressants or psychotherapy, clinicians should make an attempt to specify the subtypes of depression and to combine antidepressants and psychotherapy in a sequential approach.
Using a technique that enables them to study both early and advanced stages of arterial plaque buildup in the same mice, researchers at Cedars-Sinai Medical Center found that an antioxidant compound found in green tea leaves does not clear established plaque but does inhibit the development of new deposits.
Micromet, Inc. today announced that it has initiated a phase 2 trial of its lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE® antibodies, designed to harness the body's T cells to kill cancer cells.
› Verified 4 days ago
| NPI Number | 1538453766 |
| Organization Name | ALL-MED CARE AT HOME LLC |
| Address | 201 Penn Center Blvd, Ste 400, Pittsburgh, PA 15235 |
| Phone Number | 347-792-8182 |
News Archive
The most productive way scientists have devised to nurture colonies of human embryonic stem cells is to do so atop a bed of mouse cells. That may be fine for lab research, but it poses an unacceptable contamination risk for stem cells intended for transplant into human patients. In a new study, Brown University bioengineers have developed a synthetic bed that works about as well as the mouse cells, called fibroblasts, without any possibility of contamination.
A new paper describes the development and validation of a rapid test to measure the neutralizing activity of serum against COVID-19 using a drop of blood.
It is unlikely that different types of depression can be combined to one single disease called Major Depression. When testing the efficacy of antidepressants or psychotherapy, clinicians should make an attempt to specify the subtypes of depression and to combine antidepressants and psychotherapy in a sequential approach.
Using a technique that enables them to study both early and advanced stages of arterial plaque buildup in the same mice, researchers at Cedars-Sinai Medical Center found that an antioxidant compound found in green tea leaves does not clear established plaque but does inhibit the development of new deposits.
Micromet, Inc. today announced that it has initiated a phase 2 trial of its lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE® antibodies, designed to harness the body's T cells to kill cancer cells.
› Verified 4 days ago
| NPI Number | 1659027282 |
| Organization Name | NIGHTINGALE HOME HEALTHCARE OF CONNECTICUT INC |
| Doing Business As | NIGHTINGALE VISITING NURSES |
| Address | 9 W Broad St Ste 610, Stamford, CT 06902 |
| Phone Number | 866-334-7777 |
News Archive
The most productive way scientists have devised to nurture colonies of human embryonic stem cells is to do so atop a bed of mouse cells. That may be fine for lab research, but it poses an unacceptable contamination risk for stem cells intended for transplant into human patients. In a new study, Brown University bioengineers have developed a synthetic bed that works about as well as the mouse cells, called fibroblasts, without any possibility of contamination.
A new paper describes the development and validation of a rapid test to measure the neutralizing activity of serum against COVID-19 using a drop of blood.
It is unlikely that different types of depression can be combined to one single disease called Major Depression. When testing the efficacy of antidepressants or psychotherapy, clinicians should make an attempt to specify the subtypes of depression and to combine antidepressants and psychotherapy in a sequential approach.
Using a technique that enables them to study both early and advanced stages of arterial plaque buildup in the same mice, researchers at Cedars-Sinai Medical Center found that an antioxidant compound found in green tea leaves does not clear established plaque but does inhibit the development of new deposits.
Micromet, Inc. today announced that it has initiated a phase 2 trial of its lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE® antibodies, designed to harness the body's T cells to kill cancer cells.
› Verified 4 days ago
| NPI Number | 1770538456 |
| Organization Name | MEDI HOME HEALTH AGENCY, INC. |
| Doing Business As | MEDI HOME HEALTH AGENCY |
| Address | 201 Penn Center Blvd, Suite 300, Pittsburgh, PA 15235 |
| Phone Number | 412-702-1840 |
News Archive
The most productive way scientists have devised to nurture colonies of human embryonic stem cells is to do so atop a bed of mouse cells. That may be fine for lab research, but it poses an unacceptable contamination risk for stem cells intended for transplant into human patients. In a new study, Brown University bioengineers have developed a synthetic bed that works about as well as the mouse cells, called fibroblasts, without any possibility of contamination.
A new paper describes the development and validation of a rapid test to measure the neutralizing activity of serum against COVID-19 using a drop of blood.
It is unlikely that different types of depression can be combined to one single disease called Major Depression. When testing the efficacy of antidepressants or psychotherapy, clinicians should make an attempt to specify the subtypes of depression and to combine antidepressants and psychotherapy in a sequential approach.
Using a technique that enables them to study both early and advanced stages of arterial plaque buildup in the same mice, researchers at Cedars-Sinai Medical Center found that an antioxidant compound found in green tea leaves does not clear established plaque but does inhibit the development of new deposits.
Micromet, Inc. today announced that it has initiated a phase 2 trial of its lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE® antibodies, designed to harness the body's T cells to kill cancer cells.
› Verified 4 days ago
| NPI Number | 1932558038 |
| Organization Name | NIGHTINGALE HOSPICE CARE INC. |
| Address | 1036 S Rangeline Rd, Carmel, IN 46032 |
| Phone Number | 866-334-7777 |
News Archive
The most productive way scientists have devised to nurture colonies of human embryonic stem cells is to do so atop a bed of mouse cells. That may be fine for lab research, but it poses an unacceptable contamination risk for stem cells intended for transplant into human patients. In a new study, Brown University bioengineers have developed a synthetic bed that works about as well as the mouse cells, called fibroblasts, without any possibility of contamination.
A new paper describes the development and validation of a rapid test to measure the neutralizing activity of serum against COVID-19 using a drop of blood.
It is unlikely that different types of depression can be combined to one single disease called Major Depression. When testing the efficacy of antidepressants or psychotherapy, clinicians should make an attempt to specify the subtypes of depression and to combine antidepressants and psychotherapy in a sequential approach.
Using a technique that enables them to study both early and advanced stages of arterial plaque buildup in the same mice, researchers at Cedars-Sinai Medical Center found that an antioxidant compound found in green tea leaves does not clear established plaque but does inhibit the development of new deposits.
Micromet, Inc. today announced that it has initiated a phase 2 trial of its lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE® antibodies, designed to harness the body's T cells to kill cancer cells.
› Verified 4 days ago
| Quality Rating: |
News Archive
The most productive way scientists have devised to nurture colonies of human embryonic stem cells is to do so atop a bed of mouse cells. That may be fine for lab research, but it poses an unacceptable contamination risk for stem cells intended for transplant into human patients. In a new study, Brown University bioengineers have developed a synthetic bed that works about as well as the mouse cells, called fibroblasts, without any possibility of contamination.
A new paper describes the development and validation of a rapid test to measure the neutralizing activity of serum against COVID-19 using a drop of blood.
It is unlikely that different types of depression can be combined to one single disease called Major Depression. When testing the efficacy of antidepressants or psychotherapy, clinicians should make an attempt to specify the subtypes of depression and to combine antidepressants and psychotherapy in a sequential approach.
Using a technique that enables them to study both early and advanced stages of arterial plaque buildup in the same mice, researchers at Cedars-Sinai Medical Center found that an antioxidant compound found in green tea leaves does not clear established plaque but does inhibit the development of new deposits.
Micromet, Inc. today announced that it has initiated a phase 2 trial of its lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE® antibodies, designed to harness the body's T cells to kill cancer cells.
› Verified 4 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 96.1 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 98.5 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.9 | 99.6 |
| How often the home health team checked patients for depression | 98.2 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 84.6 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 88.5 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 99.1 | 96.4 |
News Archive
The most productive way scientists have devised to nurture colonies of human embryonic stem cells is to do so atop a bed of mouse cells. That may be fine for lab research, but it poses an unacceptable contamination risk for stem cells intended for transplant into human patients. In a new study, Brown University bioengineers have developed a synthetic bed that works about as well as the mouse cells, called fibroblasts, without any possibility of contamination.
A new paper describes the development and validation of a rapid test to measure the neutralizing activity of serum against COVID-19 using a drop of blood.
It is unlikely that different types of depression can be combined to one single disease called Major Depression. When testing the efficacy of antidepressants or psychotherapy, clinicians should make an attempt to specify the subtypes of depression and to combine antidepressants and psychotherapy in a sequential approach.
Using a technique that enables them to study both early and advanced stages of arterial plaque buildup in the same mice, researchers at Cedars-Sinai Medical Center found that an antioxidant compound found in green tea leaves does not clear established plaque but does inhibit the development of new deposits.
Micromet, Inc. today announced that it has initiated a phase 2 trial of its lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE® antibodies, designed to harness the body's T cells to kill cancer cells.
› Verified 4 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 82.1 | 79.6 |
| How often patients got better at getting in and out of bed | 81.1 | 81.1 |
| How often patients got better at bathing | 79.2 | 82.3 |
| How often patients’ breathing improved | 72.5 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 93.2 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 70.3 | 75 |
| How often home health patients had to be admitted to the hospital | 14.7 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 14.9 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 96.8 | 94 |
News Archive
The most productive way scientists have devised to nurture colonies of human embryonic stem cells is to do so atop a bed of mouse cells. That may be fine for lab research, but it poses an unacceptable contamination risk for stem cells intended for transplant into human patients. In a new study, Brown University bioengineers have developed a synthetic bed that works about as well as the mouse cells, called fibroblasts, without any possibility of contamination.
A new paper describes the development and validation of a rapid test to measure the neutralizing activity of serum against COVID-19 using a drop of blood.
It is unlikely that different types of depression can be combined to one single disease called Major Depression. When testing the efficacy of antidepressants or psychotherapy, clinicians should make an attempt to specify the subtypes of depression and to combine antidepressants and psychotherapy in a sequential approach.
Using a technique that enables them to study both early and advanced stages of arterial plaque buildup in the same mice, researchers at Cedars-Sinai Medical Center found that an antioxidant compound found in green tea leaves does not clear established plaque but does inhibit the development of new deposits.
Micromet, Inc. today announced that it has initiated a phase 2 trial of its lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE® antibodies, designed to harness the body's T cells to kill cancer cells.
› Verified 4 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
The most productive way scientists have devised to nurture colonies of human embryonic stem cells is to do so atop a bed of mouse cells. That may be fine for lab research, but it poses an unacceptable contamination risk for stem cells intended for transplant into human patients. In a new study, Brown University bioengineers have developed a synthetic bed that works about as well as the mouse cells, called fibroblasts, without any possibility of contamination.
A new paper describes the development and validation of a rapid test to measure the neutralizing activity of serum against COVID-19 using a drop of blood.
It is unlikely that different types of depression can be combined to one single disease called Major Depression. When testing the efficacy of antidepressants or psychotherapy, clinicians should make an attempt to specify the subtypes of depression and to combine antidepressants and psychotherapy in a sequential approach.
Using a technique that enables them to study both early and advanced stages of arterial plaque buildup in the same mice, researchers at Cedars-Sinai Medical Center found that an antioxidant compound found in green tea leaves does not clear established plaque but does inhibit the development of new deposits.
Micromet, Inc. today announced that it has initiated a phase 2 trial of its lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE® antibodies, designed to harness the body's T cells to kill cancer cells.
› Verified 4 days ago
The patient survey data of Medi Home Health Agency Inc is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 87 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 82 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 74 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 84 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 79 | 78 |
News Archive
The most productive way scientists have devised to nurture colonies of human embryonic stem cells is to do so atop a bed of mouse cells. That may be fine for lab research, but it poses an unacceptable contamination risk for stem cells intended for transplant into human patients. In a new study, Brown University bioengineers have developed a synthetic bed that works about as well as the mouse cells, called fibroblasts, without any possibility of contamination.
A new paper describes the development and validation of a rapid test to measure the neutralizing activity of serum against COVID-19 using a drop of blood.
It is unlikely that different types of depression can be combined to one single disease called Major Depression. When testing the efficacy of antidepressants or psychotherapy, clinicians should make an attempt to specify the subtypes of depression and to combine antidepressants and psychotherapy in a sequential approach.
Using a technique that enables them to study both early and advanced stages of arterial plaque buildup in the same mice, researchers at Cedars-Sinai Medical Center found that an antioxidant compound found in green tea leaves does not clear established plaque but does inhibit the development of new deposits.
Micromet, Inc. today announced that it has initiated a phase 2 trial of its lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory (r/r) B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE® antibodies, designed to harness the body's T cells to kill cancer cells.
› Verified 4 days ago
Interim Healthcare Of Pittsburgh, Inc. Location: Towne Ctr Offices 1789 South Braddock Ave Ste 220, Pittsburgh, Pennsylvania 15218 Ratings: Phone: (800) 447-2030 | |
Heartland Hh Care And Hospice Location: 750 Holiday Dr Foster Plaza 9, Pittsburgh, Pennsylvania 15220 Ratings: Phone: (412) 928-2126 | |
Care At Home Preferred, Inc. Location: 1388 Freeport Road Suite 101, Pittsburgh, Pennsylvania 15238 Ratings: Phone: (412) 967-1111 | |
Landmark Home Health Care Location: 209 13th Street, Pittsburgh, Pennsylvania 15215 Ratings: Phone: (412) 781-0700 | |
Medi Home Health Agency Inc Location: 201 Penn Center Blvd Ste 300, Pittsburgh, Pennsylvania 15235 Ratings: Phone: (412) 242-8540 | |
Aveanna Healthcare Location: 1501 Reedsdale St Ste 4002, Pittsburgh, Pennsylvania 15233 Ratings: NA Phone: (412) 322-4140 |